Use of different ligand modification liposomes to evaluate the anti-liver tumor activity of cantharidin

References

• Albinali, K.E., et al., 2019. A perspective on magnetic core-shell carriers for responsive and targeted drug delivery systems. International journal of nanomedicine, 14, 1707–1723.
   PubMed Web of Science ®Google Scholar
• AlSawaftah, N.M., et al., 2021. Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells. Scientific reports, 11 (1), 11589.
   PubMed Web of Science ®Google Scholar
• Chapiro, J., et al., 2014. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. Radiology, 273 (3), 746–758.
   PubMed Web of Science ®Google Scholar
• Chen, W., et al., 2021. Exosome in hepatocellular carcinoma: an update. Journal of cancer, 12 (9), 2526–2536.
   PubMed Web of Science ®Google Scholar
• Deng, L., et al., 2017. A laser-activated biocompatible theranostic nanoagent for targeted multimodal imaging and photothermal therapy. Theranostics, 7 (18), 4410–4423.
   PubMed Web of Science ®Google Scholar
• Ehexige, E., et al., 2020. Silencing of STAT3 via peptidomimetic LNP-mediated systemic delivery of RNAi downregulates PD-L1 and inhibits melanoma growth. Biomolecules, 10 (2), 285.
   PubMed Web of Science ®Google Scholar
• Farina, C., Pinza, M., and Pifferi, G., 1998. Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids. Farmaco, 53 (1), 22–32.
   PubMedGoogle Scholar
• Kong, L., et al., 2020. Transferrin-modified Osthole PEGylated liposomes travel the blood-brain barrier and mitigate Alzheimer’s disease-related pathology in APP/PS-1 mice. International journal of nanomedicine, 15, 2841–2858.
   PubMed Web of Science ®Google Scholar
• Li, W., et al., 2012. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study. BMC Cancer, 12, 547.
   PubMed Web of Science ®Google Scholar
• Li, W.J., et al., 2018. Liver-targeted delivery of liposome-encapsulated curcumol using galactosylated-stearate. Experimental and therapeutic medicine, 16 (2), 925–930.
   PubMed Web of Science ®Google Scholar
• Liu, G., et al., 2020b. Increased oxidative phosphorylation is required for stemness maintenance in liver cancer stem cells from hepatocellular carcinoma cell line HCCLM3 cells. International journal of molecular sciences, 21 (15), 5276.
   PubMed Web of Science ®Google Scholar
• Liu, K., et al., 2020a. Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients. Scientific reports, 10 (1), 21376.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2021. Higher intake of whole grains and dietary fiber are associated with lower risk of liver cancer and chronic liver disease mortality. Nature communications, 12 (1), 6388.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2020c. Targeted gene silencing BRAF synergized photothermal effect inhibits hepatoma cell growth using new GAL-GNR-siBRAF nanosystem. Nanoscale Research Letters, 15 (1), 116.
   PubMed Web of Science ®Google Scholar
• Maione, F., et al., 2019. Long-lasting anti-inflammatory and antinociceptive effects of acute ammonium glycyrrhizinate administration: pharmacological, biochemical, and docking studies. Molecules, 24 (13), 2453.
   PubMed Web of Science ®Google Scholar
• Makowski, M., et al., 2019. Advances in lipid and metal nanoparticles for antimicrobial peptide delivery. Pharmaceutics, 11 (11), 588.
   PubMed Web of Science ®Google Scholar
• Mizuhata, M., et al., 2018. Respiratory-gated proton beam therapy for hepatocellular carcinoma adjacent to the gastrointestinal tract without fiducial markers. Cancers, 10 (2), 58.
   PubMed Web of Science ®Google Scholar
• Myrhammar, A., et al., 2020. Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting. Scientific reports, 10 (1), 20777.
   PubMed Web of Science ®Google Scholar
• Pires, L., et al., 2020. Dual-agent photodynamic therapy with optical clearing eradicates pigmented melanoma in preclinical tumor models. Cancers, 12 (7), 1956.
   PubMed Web of Science ®Google Scholar
• Ruman, U., et al., 2020. Nanocarrier-based therapeutics and theranostics drug delivery systems for next generation of liver cancer nanodrug modalities. International journal of nanomedicine, 15, 1437–1456.
   PubMed Web of Science ®Google Scholar
• Schoenberg, M.B., et al., 2018. Perivascular tumor-infiltrating leukocyte scoring for prognosis of resected hepatocellular carcinoma patients. Cancers, 10 (10), 389.
   PubMed Web of Science ®Google Scholar
• Shengde, S., et al., 2010. A new synthetic method of L-menthyl-β-D-galactoside. Guangzhou chemistry, 9 (15), 113–119.
   Google Scholar
• Wancui, J., et al., 2006. Synthesis, purification and characterization of menthol glycosides. Journal of food and biotechnology, 9 (30), 115–119.
   Google Scholar
• Wang, Q.S., et al., 2019. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma. Theranostics, 9 (21), 6239–6255.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2017. XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma. Scientific reports, 7 (1), 9989.
   PubMedGoogle Scholar
• Xie, Q.L., Liu, Y., and Zhu, Y., 2016. Chromosome region maintenance 1 expression and its association with clinical pathological features in primary carcinoma of the liver. Experimental and therapeutic medicine, 12 (1), 59–68.
   PubMed Web of Science ®Google Scholar
• Xing, J., et al., 2019. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy. International journal of nanomedicine, 14, 5201–5213.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2018. A distinctively expressed long noncoding RNA, RP11-466I1.1, may serve as a prognostic biomarker in hepatocellular carcinoma. Cancer medicine, 7 (7), 2960–2968.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2017. Augmented anticancer effects of cantharidin with liposomal encapsulation: in vitro and in vivo evaluation. Molecules, 22 (7), 1052.
   PubMed Web of Science ®Google Scholar
• Zhao, M., et al., 2018. Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes. International journal of nanomedicine, 13, 1601–1610.
   PubMed Web of Science ®Google Scholar
• Zhou, L., et al., 2019. Development of 11-DGA-3-O-Gal-modified cantharidin liposomes for treatment of hepatocellular carcinoma. Molecules, 24 (17), 3080.
   PubMed Web of Science ®Google Scholar
• Zhu, J., et al., 2018. Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate. Experimental and therapeutic medicine, 16 (3), 1639–1646.
   PubMed Web of Science ®Google Scholar
• Zhu, K., et al., 2020. 18-GA-Suc modified liposome loading cantharidin for augmenting hepatic specificity: preparation, characterization, antitumor effects, and liver-targeting efficiency. Journal of pharmaceutical sciences, 109 (6), 2038–2047.
   PubMed Web of Science ®Google Scholar